Dexin (ROCO:3349) Notes Receivable: NT$0.0 Mil (As of Dec. 2025)


ROCO:3349 Dexin Corp ROCO:3349
55 GF Score
Price NT$23.90
GF Value NT$18.74
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Dexin Notes Receivable?

Dexin ROCO:3349 55 Notes Receivable is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:3349 with a GF Score™ of 55/100 and a GF Value™ of NT$18.74 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Dexin's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

Dexin Notes Receivable Historical Data

* Premium members only.

The historical data trend for Dexin's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dexin Notes Receivable Chart

Dexin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dexin Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:3349
55GF Score
Dexin Corp ROCO:3349
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dexin Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.0 Mil mean?
Dexin (ROCO:3349) has a Notes Receivable of NT$0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Dexin and its competitors.
Is Dexin's Notes Receivable too high?
Dexin's current Notes Receivable is NT$0.0 Mil. Overall, Dexin has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dexin's Notes Receivable compare to SNDK and DELL?
Dexin's Notes Receivable of NT$0.0 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Hardware company?
A good Notes Receivable depends on the Hardware industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Dexin and its competitors. Dexin's current Notes Receivable is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dexin stock overvalued right now?
Based on GuruFocus' analysis, Dexin (ROCO:3349) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$18.74, compared to a current price of NT$23.90 — trading 27.5% above its estimated fair value. The current Notes Receivable is NT$0.0 Mil. Dexin's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Dexin (ROCO:3349), the current Notes Receivable is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dexin (ROCO:3349) Overvalued in 2026?

Based on GuruFocus' analysis, Dexin stock appears to be overvalued. The current stock price of NT$23.90 is trading 27.5% above its estimated GF Value™ of NT$18.74. GuruFocus considers Dexin to be Modestly Overvalued.

Key valuation signals for ROCO:3349:

  • Notes Receivable: NT$0.0 Mil
  • GF Value™: NT$18.74 vs. price of NT$23.90 (27.5% above fair value)
  • GF Score™: 55/100 with 1 warning sign

No single metric tells the full story. See the ROCO:3349 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dexin Business Description

Address 14F-8, No.258, Liancheng Road, Zhonghe District, New Taipei, TWN, 235
Dexin Corp is a Taiwan-based company engages in the manufacture and sale of information technology (IT) input devices in Taiwan. It focuses on various cordless and corded products, such as laser mouse, optical mouse, gaming mouse, keyboard mouse set, Web camera, and Skype phone.
55GF Score

Get the complete analysis for ROCO:3349

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.90
Price
NT$18.74
GF Value